TY - JOUR
T1 - Carcinoids
T2 - The prognostic effect of primary site histologic type variations
AU - Johnson, Lewis A.
AU - Lavin, Philip T.
AU - Moertel, Charles G.
AU - Weiland, Louis H.
AU - Dayal, Yogeshwar Y.
AU - Doos, Wilhelm G.
AU - Geller, Stephen A.
AU - Cooper, Harry S.
AU - Masse, Serge R.
AU - Engstrom, Paul F.
PY - 1986/10
Y1 - 1986/10
N2 - Carcinoids are histologically classified as insular (A), trabecular (B), glandular (C), undifferentiated (D) or mixed. These have prognostic significance, i.e. Group 1 (most favorable, A+C); 2 (favorable, A, B, A+B); 3 (relatively unfavorable, all non A+C or A+B mixed types); and 4 (unfavorable, C, D). Midgut primaries have a better prognosis than either foregut or hindgut/cloacal primaries. Carcinoids from 114 Eastern Cooperative Oncology Group patients were studied to determine if primary site prognostic differences result from histologic prognostic group occurrence rate differences across primary sites. By primary site the following rates were observed: Foregut: 1 (0%), 2 (79.2%), 3 (12.5%), 4 (8.3%); midgut: 1 (26.7%), 2(58.7%), 3 (6.6%), 4 (8.0%); hindgut/cloaca: 1 (0%), 2 (42.9%), 3 (42.9%), 4 (14.2%); nongut: 1 (0%), 2 (75.0%), 3 (12.5%), 4 (12.5%), p < 0.01. The results demonstrate that primary site prognostic differences are highly dependent upon histologic prognostic group occurrence rate variations across primary sites. In addition multivariate analysis of survivorship by both histologic type (p < 0.05) and primary site (p < 0.05) demonstrated that each variable has independent prognostic significance.
AB - Carcinoids are histologically classified as insular (A), trabecular (B), glandular (C), undifferentiated (D) or mixed. These have prognostic significance, i.e. Group 1 (most favorable, A+C); 2 (favorable, A, B, A+B); 3 (relatively unfavorable, all non A+C or A+B mixed types); and 4 (unfavorable, C, D). Midgut primaries have a better prognosis than either foregut or hindgut/cloacal primaries. Carcinoids from 114 Eastern Cooperative Oncology Group patients were studied to determine if primary site prognostic differences result from histologic prognostic group occurrence rate differences across primary sites. By primary site the following rates were observed: Foregut: 1 (0%), 2 (79.2%), 3 (12.5%), 4 (8.3%); midgut: 1 (26.7%), 2(58.7%), 3 (6.6%), 4 (8.0%); hindgut/cloaca: 1 (0%), 2 (42.9%), 3 (42.9%), 4 (14.2%); nongut: 1 (0%), 2 (75.0%), 3 (12.5%), 4 (12.5%), p < 0.01. The results demonstrate that primary site prognostic differences are highly dependent upon histologic prognostic group occurrence rate variations across primary sites. In addition multivariate analysis of survivorship by both histologic type (p < 0.05) and primary site (p < 0.05) demonstrated that each variable has independent prognostic significance.
KW - Aged
KW - Carcinoid Tumor/pathology
KW - Digestive System Neoplasms/pathology
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Statistics as Topic
UR - http://www.scopus.com/inward/record.url?scp=0023037696&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:A1986E587300003&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1002/jso.2930330204
DO - 10.1002/jso.2930330204
M3 - Article
C2 - 3762189
SN - 0022-4790
VL - 33
SP - 81
EP - 83
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
IS - 2
ER -